Efficacy and Safety of PRJ212 to Improve the Memory of Patients With Mild Severity Alzheimer's Disease

NAUnknownINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 31, 2016

Primary Completion Date

July 31, 2018

Study Completion Date

December 31, 2018

Conditions

Alzheimer Disease

Interventions

DIETARY_SUPPLEMENT

PRJ212

6 capsules of study product will be taken daily and orally.

DIETARY_SUPPLEMENT

Placebo

6 capsules of study product will be taken daily and orally.

Trial Locations (1)

Fundació ACE, Barcelona